Literature DB >> 12502868

Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells.

Rosa Anna DeFilippis1, Edward C Goodwin, Lingling Wu, Daniel DiMaio.   

Abstract

Cervical cancer cells express high-risk human papillomavirus (HPV) E6 and E7 proteins, and repression of HPV gene expression causes the cells to cease proliferation and undergo senescence. However, it is not known whether both HPV proteins are required to maintain the proliferative state of cervical cancer cells, or whether mutations that accumulate during carcinogenesis eliminate the need for one or the other of them. To address these questions, we used the bovine papillomavirus E2 protein to repress the expression of either the E6 protein or the E7 protein encoded by integrated HPV18 DNA in HeLa cervical carcinoma cells. Repression of the E7 protein activated the Rb pathway but not the p53 pathway and triggered senescence, whereas repression of the E6 protein activated the p53 pathway but not the Rb pathway and triggered both senescence and apoptosis. Telomerase activity, cyclin-dependent kinase activity, and expression of c-myc were markedly inhibited by repression of either E6 or E7. These results demonstrate that continuous expression of both the E6 and the E7 protein is required for optimal proliferation of cervical carcinoma cells and that the two viral proteins exert distinct effects on cell survival and proliferation. Therefore, strategies that inhibit the expression or activity of either viral protein are likely to inhibit the growth of HPV-associated cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502868      PMCID: PMC140828          DOI: 10.1128/jvi.77.2.1551-1563.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.

Authors:  F A Dick; E Sailhamer; N J Dyson
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.

Authors:  K Butz; C Denk; A Ullmann; M Scheffner; F Hoppe-Seyler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.

Authors:  T Kanaya; S Kyo; K Hamada; M Takakura; Y Kitagawa; H Harada; M Inoue
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

4.  Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein.

Authors:  L K Naeger; E C Goodwin; E S Hwang; R A DeFilippis; H Zhang; D DiMaio
Journal:  Cell Growth Differ       Date:  1999-06

5.  Activation of p53 in cervical carcinoma cells by small molecules.

Authors:  S Hietanen; S Lain; E Krausz; C Blattner; D P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

6.  Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.

Authors:  A Nishimura; T Ono; A Ishimoto; J J Dowhanick; M A Frizzell; P M Howley; H Sakai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Rapid induction of senescence in human cervical carcinoma cells.

Authors:  E C Goodwin; E Yang; C J Lee; H W Lee; D DiMaio; E S Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

8.  Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways.

Authors:  S I Wells; D A Francis; A Y Karpova; J J Dowhanick; J D Benson; P M Howley
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

9.  Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.

Authors:  E C Goodwin; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

10.  Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.

Authors:  C Desaintes; S Goyat; S Garbay; M Yaniv; F Thierry
Journal:  Oncogene       Date:  1999-08-12       Impact factor: 9.867

View more
  130 in total

1.  Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines.

Authors:  Nifang Niu; Yuxin Qin; Brooke L Fridley; Junmei Hou; Krishna R Kalari; Minjia Zhu; Tse-Yu Wu; Gregory D Jenkins; Anthony Batzler; Liewei Wang
Journal:  Genome Res       Date:  2010-10-05       Impact factor: 9.043

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

3.  miR-29 and miR-30 regulate B-Myb expression during cellular senescence.

Authors:  Ivan Martinez; Demian Cazalla; Laura L Almstead; Joan A Steitz; Daniel DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

4.  Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.

Authors:  Monique A Morrison; Richard J Morreale; Shailaja Akunuru; Matthew Kofron; Yi Zheng; Susanne I Wells
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 5.  Regulation of apoptosis by the papillomavirus E6 oncogene.

Authors:  Ting-Ting Li; Li-Na Zhao; Zhi-Guo Liu; Ying Han; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

6.  High-throughput cell-based screen for chemicals that inhibit infection by simian virus 40 and human polyomaviruses.

Authors:  Edward C Goodwin; Walter J Atwood; Daniel DiMaio
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

7.  Cell growth inhibition in HPV 18 positive uveal melanoma cells by E6/E7 siRNA.

Authors:  Biyun Cun; Xin Song; Renbing Jia; Haibo Wang; Xiaoping Zhao; Bo Liu; Shengfang Ge; Xianqun Fan
Journal:  Tumour Biol       Date:  2013-03-14

8.  Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

Authors:  Sang-Hyuk Chung; Paul F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

9.  Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.

Authors:  Changyou Li; Daniel E Johnson
Journal:  Cell Cycle       Date:  2013-02-19       Impact factor: 4.534

10.  Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy.

Authors:  Janet L Brandsma; Ying Sun; Paul M Lizardi; David P Tuck; Daniel Zelterman; G Kenneth Haines; Maritza Martel; Malini Harigopal; Kevin Schofield; Matthew Neapolitano
Journal:  Virology       Date:  2009-05-13       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.